779 results on '"Hatano, Koji"'
Search Results
2. First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer
3. Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution
4. GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
5. Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management
6. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
7. Detection support of lesions in patients with prostate cancer using 18F-PSMA 1007 PET/CT
8. Increased volume of the left hippocampal dentate gyrus after 4 weeks of bright light exposure in patients with mood disorders: a randomized controlled study
9. Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
10. Surgical resection of primary leiomyosarcoma of retro-hepatic inferior vena cava extending from bilateral renal veins across the diaphragm
11. The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer
12. Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
13. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
14. Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
15. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients
16. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer
17. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study
18. A cross‐species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk.
19. Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
20. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer
21. Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
22. Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
23. A case of malignant pheochromocytoma with neurofibromatosis type 1 having difficulty in differentiating spinal tumor
24. MP15-04 EIF2S1 IN URINARY EXTRACELLULAR VESICLES AS A NOVEL DIAGNOSTIC MARKER FOR BLADDER CANCER
25. MP05-07 GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER FOR CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASIS VIA PROMOTING THE VICIOUS CYCLE
26. PD35-03 GENOME-WIDE CRISPR SCREENS IDENTIFIED THAT DCLRE1C REGULATES THE RADIOSENSITIVITY OF PROSTATE CANCER
27. MP41-05 LIQUID-BIOPSY BASED NOVEL mRNA GENOMIC TEST FOR EARLY DETECTION, PROGNOSIS AND MONITORING OF PROSTATE CANCER: A MULTICENTER STUDY
28. MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME
29. The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
30. Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma.
31. Cumulative Incidence and Risk Factors for Anti-Resorptive Agent-Related Osteonecrosis of the Jaw during Long-Term Prostate Cancer Management
32. Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor‐targeted therapy combinations
33. GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER BY ENHANCING THE VICIOUS CYCLE OF BONE METASTASIS
34. ALANINE RESTRICTION CAN INHIBIT CARCINOGENESIS IN A NOVEL MOUSE MODEL OF UPPER TRACT UROTHELIAL CARCINOMA
35. A retroperitoneal primary undifferentiated pleomorphic sarcoma
36. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
37. Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study
38. High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
39. Maternal overprotection predicts consistent improvement of self-compassion during mindfulness-based intervention and existential approach: a secondary analysis of the EXMIND study
40. FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab
41. Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma
42. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
43. Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects
44. MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma
45. Long-term safety and efficacy of enzalutamide for men with castration-resistant prostate cancer: a multicenter, prospective DELC study
46. Increasing the uptake of 18F‐fluorodeoxyglucose in the left hippocampus after 4 weeks of bright light exposure in healthy participants: A randomized controlled study
47. Cyclothymic temperament and glucose metabolism in the right superior parietal lobule
48. Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report
49. Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma
50. EIF2S1 as a novel diagnostic marker for bladder cancer in urinary extracellular vesicles.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.